Cardiometabolic Screening Program
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
About this trial
This research study is being done to implement a screening program for prediabetes, diabetes, dyslipidemia and/or hyperlipidemia, and higher risk of cardiovascular disease in breast cancer survivors. This program will also help to direct individuals with risk factors to community and institutional resources for management.
Eligibility criteria
Qualifiers
Diagnosis of early stage breast cancer
Completed local and/or systemic therapy at least 3 months ago
Receiving medical oncology care at through the breast cancer clinics at Johns Hopkins Medical Institute, including the Sidney Kimmel Comprehensive Cancer Center in Baltimore MD and Green Spring Station in Lutherville-Timonium MD, and Sibley Memorial Hospital in Washington D.C.
Read and speak English
Disqualifiers
Metastatic breast cancer
Trial design
Treatments tested in this trial
- Prescreening
- Screening and Enrollment
- Baseline
- Interpret BMI
- Interpret HbA1c
- Interpret lipid panel and assess other risk factors
- Assess 10 year risk of cardiovascular event
- Recommendations
- Follow-Up
Treatment groups
450 Participants
are divided into 1 treatment groupLocations
1Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins21231-1000, BaltimoreMaryland, United States
Sponsors and collaborators
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Lead sponsor
Private Philanthropic Funds
Collaborator
Source ClinicalTrials.gov